SEARCH

SEARCH BY CITATION

References

  • 1
    Koopmans M, Wilbrink B, Conyn M et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands [see comment]. Lancet 2004; 363:587593.
  • 2
    CDC. Avian Influenza Infection in Humans. 2006. Available from: http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm (accessed 12 January 2006).
  • 3
    Tweed SA, Skowronski DM, David ST et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004; 10:21962199.
  • 4
    Centers for Disease Control and Prevention. Isolation of avian influenza A(H5N1) viruses from humans – Hong Kong, May–December 1997. MMWR – Morb Mortal Wkly Rep 1997;46:12041207.
  • 5
    Uyeki TM, Chong YH, Katz JM et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis 2002; 8:154159.
  • 6
    Centers for Disease Control and Prevention. Update: Influenza Activity – United States and Worldwide, May 20–September 15, 2007. MMWR – Morb Mortal Wkly Rep 2007; 56:10011004.
  • 7
    Centers for Disease Control and Prevention. Update: influenza activity – United States, September 30–December 1, 2007. MMWR – Morb Mortal Wkly Rep 2007; 56:12871291.
  • 8
    Fedorko DP, Nelson NA, McAuliffe JM, Subbarao K. Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2. J Clin Microbiol 2006; 44:15961597.
  • 9
    CDC-NIH. Interim CDC-NIH Recommendation for Raising the Biosafety Level for Laboratory Work Involving Noncontemporary Human Influenza Viruses. Excerpted from the Draft Biosafety in Microbiological and Biomedical Laboratories, 5th edn. 2006. Available from: http://www.cdc.gov/flu/h2n2bsl3.htm (accessed 12 January 2006).
  • 10
    Bright RA, Medina MJ, Xu X et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern [see comment]. Lancet 2005; 366:11751181.
  • 11
    Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005–2006 influenza season in the United States [see comment]. JAMA 2006; 295:891894.
  • 12
    Centers for Disease Control and Prevention. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents – United States, 2005–06 influenza season. MMWR – Morb Mortal Wkly Rep 2006; 55:4446.
  • 13
    WHO. WHO Recommended Surveillance Standards, 2nd edn. 2006. Available from: http://www.who.int/csr/resources/publications/surveillance/WHO_CDS_CSR_ISR_99_2_EN/en/ (accessed 12 January 2006).
  • 14
    Schrag SJ, Shay DK, Gershman K et al. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003–2004. Pediatr Infect Dis J 2006; 25:395400.
  • 15
    Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children [see comment]. N Engl J Med 2006; 355:3140.
  • 16
    Grijalva CG, Craig AS, Dupont WD et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006;12:103109.
  • 17
    Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States [see comment]. JAMA 2003; 289:179186.
  • 18
    Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006; 194(Suppl. 2):S82S91.
  • 19
    Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children [see comment]. N Engl J Med 2000; 342:232239.
  • 20
    Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003–2004 [see comment]. N Engl J Med 2005; 353:25592567.